查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球髓內釘市場-2022-2029
市場調查報告書
商品編碼
1140741

全球髓內釘市場-2022-2029

Global Intramedullary Nails Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

增加老年人口是市場增長的驅動力

據說老年人（65歲以上）受傷的風險很高，即使是很小的力量也很容易損壞。因此，老年人在高衝擊或低衝擊過程中發生致命骨折的風險增加。在 50 歲以上的女性中，每 10 名女性中就有 4 名會在其一生中經歷髖部、椎骨或前臂骨折，她們死於骨折並發症的可能性比死於乳腺癌的可能性更大。 NCBI 在 2020 年發布的一份報告顯示，在 2015 年至 2025 年間，西班牙將發生大約 347,564 例髖部骨折。髖部骨折影響超過 85% 的 65 歲以上人群。因此，老年人口的增加將加速市場增長。此外，受傷和運動事故數量的增加、退行性骨病患病率的增加、老年人口的增加等預計將推動市場增長。在不久的將來，創傷固定係統的技術發展預計將增加全球需求。

然而，政府對骨科植入物的嚴格規定以及與使用髓內釘相關的併發症預計將成為預測期內抑制全球市場增長的主要因素。

地理滲透率

北美地區有望主導全球髓內釘市場

該研究按地區分析了全球市場的髓內釘市場，包括北美、歐洲、亞太地區、南美、中東和非洲。

2021 年，北美將主導全球髓內釘市場。在北美，預計美國在預測期內將出現大幅增長。由於其完善的醫療基礎設施和高昂的人均醫療費用，該國擁有巨大的髓內釘市場。此外，預計歐洲在預測期內的價值將出現顯著增長。受傷和交通事故數量的增加預計將推動該地區的市場增長。

由於人口眾多，主要在印度和中國，預計亞太地區的髓內釘市場將在預測期內快速增長。此外，骨科疾病患病率的增加和經濟增長預計將推動亞太地區髓內釘市場的增長。

競爭格局

髓內釘市場對全球市場增長做出貢獻的主要參與者包括 B. Braun Melsungen AG、Zimmer Biomet、Smith+Nephew、Johnson &Johnson、Orthopaedic Implant Company、Orthofix Holdings, Inc、Wright Medical Group N.V., Advanced Orthopaedic Solutions、Aysam Ortopedi &Tibbi Cihazlar等。領先的公司正在為髓內釘市場的全球增長採用新型的推出和擴張戰略。 2022 年 9 月，Stryker 推出了新的 Gamma4 髖部骨折釘系統。新的 Gamma 系統為外科醫生提供了 Stryker 的下一代髓內釘系統。該系統用於治療穩定性和不穩定性骨折，穩定骨骼，並糾正頭部、轉子、轉子下和股骨幹的骨骼畸形。該系統用於許多功能，包括將刮削機率降低 66% 的精密銷。 2021 年 9 月，B.Braun Melsungen AG 完成了對 Sterinova Inc. 的收購。

此外，Sterinova 將繼續作為 B.Braun 的子公司運營。 2022 年 3 月，B. Braun 收購了專門從事透析濃縮物製備的 Intermedt Medizin & Technik GmbH。此次收購完善了 B.Braun Avitum 部門作為體外血液治療（透析）系統供應商的廣泛產品組合。

COVID-19 的影響。全球髓內釘市場穩步增長

由於非 COVID-19 相關的醫療保健設施以正常速度運行，預計全球對髓內釘的需求增長將在整個 COVID-19 流行期間保持穩定。在當前的 COVID-19 大流行之後，髓內釘市場預計將保持穩定。外科和外科護理被列為具有全球重要性的設施。市場進入者必須解決由 COVID-19 大流行引起的供應鏈問題並設計適當的解決方案。

全球髓內釘市場報告包括大約 69 個市場數據表、61 個圖表和 170 頁

內容

第 1 章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按類型劃分的市場細分
  • 按材料劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 老年人口增加
      • 運動傷害和交通事故增加
    • 抑制因素
      • 針對骨科植入物的嚴格政府法規
    • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 長伽馬指甲 (LGN)
  • 股骨轉子釘 (TFN)
  • Inter troche/sub troche nail (ITST)
  • 其他

第 8 章按材料分類

  • 鈦
  • 不銹鋼

第 9 章按應用程序

  • 股骨骨折
  • 脛骨骨折
  • 其他

第 10 章最終用戶

  • 醫院和門診外科診所
  • 專科診所/骨科診所

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 13 章公司簡介

  • Stryker
    • 公司概況
    • 產品組合和內容
    • 主要亮點
    • 財務摘要
  • B. Braun Melsungen AG.
  • Zimmer Biomet.
  • Smith+Nephew.
  • Johnson & Johnson.
  • Orthopaedic Implant Company.
  • Orthofix Holdings
  • Wright Medical Group N.V
  • Advanced Orthopaedic Solutions
  • Aysam Ortopedi & Tibbi Cihazlar（*LIST NOT EXHAUSTIVE）

第 14 章重要注意事項

第 15 章 DataM

簡介目錄
Product Code: DMPH3138

Market Overview

Intramedullary Nails Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 6.5 % during the forecast period (2022-2029).

The intramedullary nail is a metal rod threaded into and through the crack of the medullary cavity of a bone to provide strong protection for the broken bone. For the treatment of femoral shaft fractures, intramedullary nailing is currently considered the gold standard. For most fractures, intramedullary fixation is useful and necessary. Nailing may be applied on proximal and distal extra-articular fractures for more modern nail styles and attention to technique. The growth of the global market for intramedullary nails is projected to rely primarily on the volume of operations undertaken to restore fractured bones. In addition, intramedullary nail fixation has emerged as the gold standard procedure for femoral shaft fractures, a trend predicted during the projected timeframe to fuel the global demand for intramedullary nails.

Market Dynamics: Increasing geriatric population drives market growth

Older adults (65 and up) have a higher risk of injuries and are more vulnerable to damage from even slight force. As a result, older people are at a greater risk of catastrophic fracture through high- or low-impact processes. Four out of every ten women over the age of 50 will undergo a hip, vertebral, or forearm fracture during their lifespan and are more likely to die from fracture complications than breast cancer. A report released by the NCBI in 2020 revealed that between 2015 and 2025, there were about 347,564 hip fractures in Spain. Hip fractures impact more than 85% of people over the age of 65. Thus, the increase in the older population accelerates the market growth. Additionally, the market growth is expected to be fueled due to an increase in injury/sports accidents, an increase in the prevalence of degenerative bone diseases, and an increasing geriatric population. It is expected that technical developments in trauma fixation systems will expand the global demand in the near future.

However, the stringent government regulations for orthopedic implants coupled with the complications associated with the use of intramedullary nails is a key factor expected to curtail the growth of the global market over the forecast period.

Market Segmentation: The trochanteric femoral nail (TFN) segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the intramedullary nails market has been classified into long gamma nail (LGN), trochanteric femoral nail (TFN), intertroch/subtroch nail (ITST), and others.

Trochanteric femoral nails (TFN) dominated the global market in 2021, whereas the long gamma nail (LGN) is expected to present considerable growth in the near future. It is intended to treat stable and unstable proximal femur fractures, including basal neck fractures, intertrochanteric fractures, and pertrochanteric fractures and combinations. Therefore, the increasing usage of Trochanteric Femoral nails in the treatment is expected to propel segmental growth in the near future.

The global intramedullary nails are segmented on the basis of material, which includes titanium and stainless steel.

Titanium is expected to hold a significant market share in the intramedullary nails market. The added advantages of titanium, such as better biocompatibility and durability, support the segment growth during the forecast period. Moreover, titanium is expected to project a considerable CAGR during the forecast period.

Geographical Penetration: North America region is expected to dominate the global intramedullary nails market

Based on geography, the study analyzes the intramedullary nails market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is holding a dominant position in the global intramedullary nails market in 2021. In North America, the U.S. is expected to represent considerable growth during the forecast period. Well-established healthcare infrastructure and high healthcare expenditure per capita in the country result in a huge market for intramedullary nails. Moreover, Europe is expected to represent significant growth in terms of value during the forecast period. The increasing number of injuries and road accidents is expected to propel market growth across the region.

The intramedullary nails market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China. Moreover, an increase in the incidence of orthopedic diseases and economic growth are expected to augment the growth of the Asia Pacific intramedullary nails market.

Competitive Landscape:

The key intramedullary nails market players which are contributing to the growth of the global market include Stryker, B. Braun Melsungen AG., Zimmer Biomet., Smith+Nephew., Johnson & Johnson., Orthopaedic Implant Company., Orthofix Holdings, Inc, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Aysam Ortopedi & Tibbi Cihazlar, among others. The major players are adopting new Type launch and expansion strategies for global growth in the intramedullary nails market. In September 2022, Stryker launched New Gamma4 Hip Fracture Nailing System. This new Gamma System gave surgeons the next generation of Stryker's intramedullary nailing system. This system is indicated for the treatment of stable and unstable fractures as well as for the stabilization of bones and correction of bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur. This system is used in different features like precision pin, which reduce the potential of skiving by 66%. In September 2021, B.Braun Melsungen AG completed the acquisition of Sterinova Inc.

Furthermore, Sterinova continues to operate as a subsidiary of B.Braun. In March 2022, B.Braun acquired Intermedt Medizin & Technik GmbH, a specialist in preparing dialysis concentrates. Through this acquisition, the company completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).

COVID-19 Impact: Stable growth of the global intramedullary nails market.

The growth of the global demand for intramedullary nails is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for intramedullary nails is expected to stay stable in the wake of the current COVID-19 pandemic. Surgeries and surgical treatments are listed as critical facilities worldwide. Market participants must solve the supply chain issues raised by the COVID-19 pandemic and design appropriate solutions to resolve them.

The global intramedullary nails market report would provide an access to approximately 69 market data tables, 61 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Material
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Geriatric Population
      • 4.1.1.2. Increasing cases of Sports Injuries and Road Accidents
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent Government Regulations for Orthopedic Implants
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Long gamma nail (LGN)*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Trochanteric femoral nail (TFN)
    • 7.3.3. Intertroch/subtroch nail (ITST)
    • 7.3.4. Others

8. By Material

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
  • 8.3. Market Attractiveness Index, By Material Segment
    • 8.3.1. Titanium*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Stainless Steel

9. By Application

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 9.3. Market Attractiveness Index, By Application Segment
    • 9.3.1. Femoral Fracture*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Tibial Fracture
    • 9.3.3. Others

10. By End User

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 10.3. Market Attractiveness Index, By End User Segment
    • 10.3.1. Hospitals & Ambulatory Surgical Clinics*
      • 10.3.1.1. Introduction
      • 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 10.3.2. Specialty/Orthopedic Clinics

11. By Region

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 11.3. Market Attractiveness Index, By Region
  • 11.4. North America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. U.S.
      • 11.4.7.2. Canada
      • 11.4.7.3. Mexico
  • 11.5. Europe
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. Germany
      • 11.5.7.2. U.K.
      • 11.5.7.3. France
      • 11.5.7.4. Italy
      • 11.5.7.5. Spain
      • 11.5.7.6. Rest of Europe
  • 11.6. South America
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.6.7.1. Brazil
      • 11.6.7.2. Argentina
      • 11.6.7.3. Rest of South America
  • 11.7. Asia Pacific
    • 11.7.1. Introduction
    • 11.7.2. Key Region-Specific Dynamics
    • 11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.7.7.1. China
      • 11.7.7.2. India
      • 11.7.7.3. Japan
      • 11.7.7.4. Australia
      • 11.7.7.5. Rest of Asia Pacific
  • 11.8. Middle East and Africa
    • 11.8.1. Introduction
    • 11.8.2. Key Region-Specific Dynamics
    • 11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Stryker*
    • 13.1.1. Company Overview
    • 13.1.2. Type Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. B. Braun Melsungen AG.
  • 13.3. Zimmer Biomet.
  • 13.4. Smith+Nephew.
  • 13.5. Johnson & Johnson.
  • 13.6. Orthopaedic Implant Company.
  • 13.7. Orthofix Holdings
  • 13.8. Wright Medical Group N.V
  • 13.9. Advanced Orthopaedic Solutions
  • 13.10. Aysam Ortopedi & Tibbi Cihazlar (*LIST NOT EXHAUSTIVE)

14. Premium Insights

15. DataM Intelligence Analysis

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us